These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 37166270

  • 1. Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer.
    Quhal F, Bryniarski P, Rivas JG, Gandaglia G, Shariat SF, Rajwa P.
    Curr Opin Urol; 2023 Jul 01; 33(4):269-273. PubMed ID: 37166270
    [Abstract] [Full Text] [Related]

  • 2. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.
    Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A.
    Eur Urol; 2020 Nov 01; 78(5):661-669. PubMed ID: 32624288
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
    Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A.
    Eur Urol; 2019 Jan 01; 75(1):176-183. PubMed ID: 30301694
    [Abstract] [Full Text] [Related]

  • 8. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
    Abdollah F, Briganti A, Montorsi F, Stenzl A, Stief C, Tombal B, Van Poppel H, Touijer K.
    Eur Urol; 2015 May 01; 67(5):839-49. PubMed ID: 24698524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
    Falkenbach F, Knipper S, Koehler D, Ambrosini F, Steuber T, Graefen M, Budäus L, Eiber M, Lunger L, Lischewski F, Heck MM, Maurer T.
    World J Urol; 2023 Sep 01; 41(9):2343-2350. PubMed ID: 37515651
    [Abstract] [Full Text] [Related]

  • 12. Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?
    McCloskey H, Jacobs J, Zambrano I, Moore T, Khandani AH, Bjurlin MA.
    Curr Urol Rep; 2020 Nov 07; 21(12):62. PubMed ID: 33159608
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
    Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A.
    Eur Urol; 2015 Feb 07; 67(2):299-309. PubMed ID: 24571959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
    Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A.
    Eur Urol Oncol; 2022 Jun 07; 5(3):285-295. PubMed ID: 34176768
    [Abstract] [Full Text] [Related]

  • 16. [Salvage lymph node dissection for nodal recurrent prostate cancer].
    Stolzenbach LF, Knipper S, Maurer T.
    Aktuelle Urol; 2020 Jun 07; 51(3):258-264. PubMed ID: 32219775
    [Abstract] [Full Text] [Related]

  • 17. The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
    Porres D, Pfister D, Thissen A, Kuru TH, Zugor V, Buettner R, Knuechel R, Verburg FA, Heidenreich A.
    Prostate Cancer Prostatic Dis; 2017 Mar 07; 20(1):85-92. PubMed ID: 27824042
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J.
    Investig Clin Urol; 2018 Mar 07; 59(2):83-90. PubMed ID: 29520383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.